Thiazolobenzimidazoles, a Novel Class of Enterovirus Inhibitors, Target the 2C Protein

Angelo DePalma; Ward Heggermont; De Clercq Erik; Alba Chimirri; Johan Neyts

doi:10.1016/j.antiviral.2007.01.149

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2004

A novel class of HIV inhibitors that target the cellular CD4 receptor

Kurt Vermeire, T.W. Bell, De Clercq Erik, Dominique Schols

Article2008

The Thiazolobenzimidazole TBZE-029 Inhibits Enterovirus Replication by Targeting a Short Region Immediately Downstream from Motif C in the Nonstructural Protein 2C

Armando M. De Palma, Ward Heggermont, Kjerstin Lanke, Bruno Coutard, Mirko Bergmann, Anna‐Maria Monforte, Bruno Canard, De Clercq Erik, Alba Chimirri, Gerhard Pürstinger, Jacques Rohayem, Frank J. M. van Kuppeveld, Johan Neyts

Article2003

A novel domain in the protein kinase SOS2 mediates interaction with the protein phosphatase 2C ABI2

Masaru Ohta, Yan Guo, Ursula Halfter, Jian Kang Zhu

Article2009

Capsid (CA) Protein as a Novel Drug Target: Recent Progress in the Research of HIV-1 CA Inhibitors

Jiyan Zhang, Xinyong Liu, De Clercq Erik

Article2009

Mutations in the Nonstructural Protein 3A Confer Resistance to the Novel Enterovirus Replication Inhibitor TTP-8307

Armando M. De Palma, Hendrik Jan Thibaut, Lonneke van der Linden, Kjerstin Lanke, Ward Heggermont, Stephen Ireland, Robert Andrews, Murty N. Arimilli, Taleb H. Al‐Tel, De Clercq Erik, Frank J. M. van Kuppeveld, Johan Neyts